ACE2 and COVID-19: This is consistent with data on frequent olfactory and taste disorders in patients with COVID-19 (85.6% and 88.0%, respectively) [20] It is reported ACE2 is expressed in a number of olfactory epithelial cells including supporting epithelial cells, basal epithelial cells, and Bowman gland cells [21].